Structures of new antifungal antibiotics, benanomicins A and B were determined to be N-[[5-[6-deoxy-3-O-(beta-D-xylopyranosyl)-beta-D-galactopyranosyloxy+ ++ ]-5, 6-dihydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo++ + [a]naphthacen-2-yl]carbonyl]-D-alanine and N-[[5-[4-amino-4,6-dideoxy-3-O-(beta-D-xylopyranosyl)-beta-D- galactopyranosyloxy]-5,6-dihydro-1,6,9,14-tetrahydroxy-11-methoxy- 3-methyl-8,13-dioxobenzo[a]naphthacen-2-yl]carbonyl]-D-al ani ne, respectively, by spectral analyses and chemical degradation studies.
No takes yet. Share an insight, caveat, or question.
Gomi et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: